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1 Introduction
After several years of neglect, industrial economists have recently devoted considerable
attention to the processes of corporate growth. Most empirical studies in this eld are
based on testing the Law of Proportionate E¤ects, also known as Gibrats Law (Gibrat,
1931), which assumes that rms size follows a random walk and hence that rms growth
is erratic. Consequently, there would be no convergence of rms size within or across
industries, and no stable or predictable di¤erences in growth would exist either in the short
or in the long run. Rather, growth would be driven by small idiosyncratic shocks.1
Gibrats Law was originally used as an explanation of the highly skewed rms size distri-
butions. Even if the growth rate of each rm in an industry is unrelated to its current size,
the variance of the rm size distribution and the level of concentration increase over time
(Simon and Bonini, 1958, Ijiri and Simon 1974 and 1977). Subsequently, the Law of Pro-
portionate E¤ects has become a referent model for discussing the processes of rms growth.
Nevertheless, Gibrats Law contrasts with most fundamental theories of rms growth (see
Geroski, 1999). The Law of Proportionate E¤ects does not hold in standard models of
convergence to an optimal size. More recent models of rms growth and industry dynamics
assume heterogeneous rms, facing idiosyncratic sources of uncertainty and discrete events.
Market selection a¤ects rms, so that the most e¢ cient grow while the others shrink and
eventually leave the market. These models imply several violations of standard Gibrat-type
processes. In particular, while (almost) all are able to generate skewed - typically log normal
- distributions of rms size, they also predict that Gibrats Law holds for large rms, while
small rms - conditional on their survival - will grow faster than older, larger companies
- i.e. mean reversion.2 If rms started with equal size, they will converge to the same
steady state. If rms started with di¤erent initial size, they will converge to di¤erent sizes.
However, mean reversion implies that the initial di¤erences in size should become smaller
in the steady state.
Lucas (1978) suggests a model which yields a skewed distribution of rms size as a result
of an optimal allocation problem, given a two inputs production function augmented with
a third factor - managerial talent - unevenly distributed among the workforce. The model
is compatible with Gibrats Law only under specic conditions. . In Jovanovics model
(Jovanovic, 1982) rms are assumed to be endowed with time-invariant characteristics (i.e.
e¢ ciency parameters), whose true value is unknown to the rm. But, by producing, the rm
1For a recent discussion, see Sutton (1997), Bottazzi et al. (2001), and Wit (2005).
2Most models also predict that the variance in growth rates will fall with size and age.
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learns about the true e¢ ciency parameter. Consequently, the most e¢ cient rms survive
and grow, while the others shrink or exit from the market. Smaller, younger rms will grow
faster than large ones - conditional on survival - since it takes time to learn about their
e¢ ciency, while large, older tend to remain close to their "optimal" size.
Ericson and Pakes (1995) make the same prediction. However, the "passive learning"
model employed by Jovanovic is replaced by an "active learning" model, where rms are
able- through investing - to improve their e¢ ciency parameter. Also Hopenhayns model
(Hopenhayn, 1992) implies regression to the mean in rms size and convergence to di¤erent
steady states sizes. Klette and Kortum (2004) develop a model which explicitly refers to
Penroses insight that rms growth is constrained by its internal resources. In Klette and
Kortum model, a rm of any size adds new products by innovating, but its likelihood of
success depends on knowledge capital accumulated through past innovations. Given specic
assumptions on the arrival rate of new innovations, the model generates a stable skewed
distribution of rm sizes, resulting from decreasing growth rates among surviving small
companies while Gibrats Law holds for large rms.
Finally, evolutionary models of rms growth based on organisational capabilities (Nelson
and Winter 1982, Dosi et al., 1995; Winter et al., 2000) are intrinsically at odds with both
Gibrats Law and theories predicting convergence to the same "optimal" size". However, an
evolutionary, competence-based approach is entirely consistent with the observation of the
lack of any strong relationship between rms size and growth. Firms growth would be the
outcome of the accumulation of new competences and market selection processes favouring
more e¢ cient and penalising less e¢ cient companies, with size per se not attributing any
intrinsic advantage or disadvantage to rms. To the extent that - and in technological
regimes where - such competences evolve in a systematic and cumulative way, one would
expect that rms growth processes exhibited a much stronger systematic component than
predicted by Gibrats Law. Conversely, new, small rms, if embodying superior technolo-
gies, may grow faster than old incumbents locked-in in their inferior capabilities. Thus,
evolutionary models would predict convergence to di¤erent sizes, with mean reversion be-
ing highly sector-specic. Skewed distributions of rms sizes may result from aggregation
of diverse rms behaviour and sectors characterised by di¤erent regimes of technological
learning and market selection (Dosi et al. 1995; Dosi, 2005)
Moreover, Gibrats Law is at odds with other observed empirical phenomena like the
persistence of heterogeneity in some rms, performance measures , e.g. prots, productivity
and - more controversially - innovation (see Baily and Chakrabarty, 1985; Mueller,1990;
3
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Geroski et al., 1993; Ces and Orsenigo, 2001; Ces, 2003). However, the hypothesis that
rms growth rates are erratic- at least for large, old rms - has often been considered a
stylised fact (Geroski,1999). More generally, Gibrats Law enters in the models and in the
empirical discussion as a fundamental way of conceptualising rms growth (Klette et al.,
2000; McCloughan, 1995, Geroski et al.2003) and models capable of yielding random growth
(Sutton, 1997, Geroski et al., 1997; Wit, 2005).
A large body of empirical literature has explored this issue using di¤erent datasets and
statistical methodologies. Typically, the the analysis starts with a simple econometric model
having the following form:
lnSit = 0 +  lnSit 1 + uit (1)
where Sit is the size of rm i at time t, and uit is an i.i.d. shock.
Gibrats Law would be conrmed if the model Mo :  = 1 could not be rejected versus
the alternative M1 :  < 1. Empirical results are controversial. Some early studies (Hart
and Prais, 1956; Simon and Bonini, 1958; Hymer and Pashigian, 1962) conrm the view
that rms size follows a random walk ( = 1), at least for large rms (Hall, 1987; Lotti,
et al., 2003). Nevertheless, a considerable body of results rejects Mo, suggesting that rms
size is mean reverting (Baldwin 1995, ch.5; Baily et al., 2000) ; conditional on rm survival,
average rm growth (and its variance) declines with size, holding age constant (Dunne et
al., 1989; Evans, 1987a, 1987b; Hall, 1987, Caves, 1998).3 In some versions, Gibrats Law is
considered to hold for large rms, whereas smaller companies grow faster, but with a higher
variance.
This work reconsiders these issues by addressing four interrelated questions. The rst
two are quite conventional. First, we ask if Gibrats law holds, by testing the random walk
assumption. Second, we verify the existence and extent of mean reversion. The following
two issues are simple, but less conventional. Specically, third, we check whether rms
converge to a common steady state (as implied by the mean reversion argument with rms
starting with equal size) or to a rm-specic steady state size (which would occur if rms
started with di¤erent initial size). Fourth, in the latter case we investigate if there is a
non-negligible number of initial smaller rms able to catch-up or even to forge ahead: this
result could conrm the existence of mean reversion for initially heterogeneous companies.
Conversely, if initial size di¤erences persist, the standard observation that small rms grow
3Di¤erentials in growth rates have been explained with rms age (Mata, 1994; Dunne, Roberts and
Samuelson, 1989)), rms size (Harho¤, Stahl and Woywode, 1998; Hart and Oulton, 1996; Hall, 1987; Evans
1987a and 1987b) or both (Farinas and Moreno, 2000).
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faster than large ones would be weakened: rms growth would depend on rm-specic
characteristics unrelated to size as such.
These exercises are prompted by the high degree of heterogeneity observed among rms,
even in very narrowly dened industries and lines of business. Such heterogeneity might
signicantly inuence the basic results obtained in the Gibrats Law literature.
To answer these questions, we adapt a hierarchical Bayesian normal linear model (Lind-
ley and Smith, 1972) to autoregressive panel data, i.e. data consisting of many time series
generated by the same type of autoregressive model. The motivation for such statistical
framework can be articulated in several points.
First, the autoregressive model is chosen for sake of consistency with previous empirical
studies.
Second, the results on Gibrats law and its implications crucially depend on the total
variation,. Previous studies attempt to verify Gibrats law using either classical modelling of
time series and cross sectional data, or short-panel econometric techniques with homogeneity
in parameters across units and over time. We consider these approaches as problematic.
First, cross section analysis ignores important information contained in unit-specic
time variation in growth rates. Also, forcing the parameters to be the same across units is
too restrictive. Recent studies (e.g. Pesaran and Smith, 1996) have shown that imposing
the slope parameter to be homogeneous in an autoregressive panel data model distorts the
estimation value of the parameter  towards the unit, irrespective of its true value, thus
rendering the Gibrats law test less powerful (see Goddard et al., 2002).
Alternatively, one can estimate equations like (1) by rm. Indeed, Geroski et al. (2003)
tested Gibrats Law on a sample of large British rms over a period of 30 years, allowing
for heterogeneity in both intercept and slope of equation (1). The test is applied to each
rm.Results show that rm size does not converge to either a common steady state or to a
set of stable di¤erences between rms. The main limitation of this procedure is that it can
be applied only for large time spans , which can be problematic for micro data.
Second, the hierarchical model approach reduces the estimation variability and exploits
coe¢ cient similarities across rms without imposing the same population structure. Con-
cretely, the model allows for an exchangeable scheme where the parameter vectors vary
across rms, subject to a common distribution with unknown means and variance. In this
sense, the model represents a satisfactory compromise between the regression model with
the same coe¢ cient for all rms and the time series regressions with di¤erent coe¢ cients
across rms.
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Third, given the hierarchical model specication, the verication of Gibrats law is based
more on the autoregressive parameter of the common underlying distributions than on the
identication of rm-specic coe¢ cients. (Li, 1999).
Finally, in situations where several short time series are simultaneously modelled, the
Bayesian paradigm is attractive by o¤erring a natural scheme for combining and weighting
data from similar sources (Nandram and Petruccelli, 1997). The Bayesian estimation of
this hierarchical model is also computationally straightforward due to recent advances in
Bayesian statistics and Markov Chain Monte Carlo Methods (see Gelfand and Smith, 1990
and Hsiao et al., 1999).
All these considerations justify the use of the Bayesian hierarchical model whose main
characteristic, complete heterogeneity, has the useful feature of exploiting all the informa-
tion contained in the panel data set in a more powerful way.
Using a sample of 210 rms from a Pharmaceutical Industry Database covering the
period 1987-1998, we do not nd strong support for the law. Moreover, data show only
weak evidence of mean reversion. Finally, di¤erences in growth rates and in steady state
size are rm-specic and, di¤erently from the results of Geroski et al (2003), persistent.
The specied model adequately ts the data and results prove to be robust to more general
sets of prior information.
The paper is structured as follows. Section 1 discusses the statistical model. Section 2
describes data and comments on the estimation results. Section 3 checks the robustness of
the results. Section 4 concludes
2 Model specication and Bayesian analysis
The evolution of size for all units is determined by a doubled indexed stochastic process
fSitg, where i 2 I indexes rms, t = 0; 1; :: indexes time, and I is the set of the rst n
integers. Following Sutton (1997), if "it is a random variable denoting the proportionate
rate of growth between period t  1 and t for rm i, then
Sit   Sit 1 = "itSit 1
and
Sit = (1 + "it)Sit 1 = Si0 (1 + "i1) (1 + "i2) ::: (1 + "it)
6
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Considering a short period of time, "it can be regarded as small and the approximation
ln (1 + "it) = "it can be justied. Hence, taking logs, we have
lnSit ' lnSi0 +
TX
t=1
"it
If the increments "it are independently and normally distributed, then lnSit follows a ran-
dom walk and the limiting distribution of Sit is lognormal. Therefore, the growth of the
rm is unrelated to its current size and only depends on the sum of idiosyncratic shocks.
Hence, to test Gibrats law, the vast majority of previous literature has used the following
general logarithmic specication
lnSit = i0 +  lnSit 1 + uit (2)
where Sit is the size of rm i at time t, and uit is a random variable that satises
E (uit j Sit s; s > 0) = 0
E (uituj j Sit s; s > 0) =

2 i = j; t = 
0 otherwise
Gibrats law is conrmed if the hypothesis  = 1 is not rejected by the data against  < 1 .
An equivalent specication used by the literature and based directly on corporate growth
rates is
ln
Sit
Sit 1
= i0 + 1 lnSit 1 + uit
where clearly 1 =  1: In this case Gibrats law is conrmed if data do not reject 1 = 0,
against 1 < 0.
4
In this work we follow a similar autoregressive specication, introducing three main inno-
vations with respect to the traditional empirical approaches. First, we study the behaviour
of the (log of) each units size relative to the average, i.e. of the variable git = ln
 
Sit= St

,
where St represents the average size over all units at each time t. The use of the proportion
of size git as our basic variable, instead of (the log of) plain size Sit; alleviates problems of
serial and residual correlation, in that possible common shocks are removed by the normal-
isation. Moreover, the variable git can be interpreted as the rms market share. Second,
we assume that even rms belonging to the same industries can di¤er substantially from
4 In both cases the test is a one-tail test, the same that we use in our empirical analysis for consistency
with the literature on testing for unit root. Note also that  > 1 (1 > 0) implies explosive growth paths,
i.e., rms grow faster as they get larger. This situation is conceivable for a short period, but not indenitely.
Moreover, from a qualitative perspective its implications for market structure are similar to those of  = 1:
concentration would increase over time, although at a faster rate.
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each other. This (possibly intrinsic) heterogeneity is modelled in a general way by allowing
all unknown parameters to be unit-specic. Finally, the latter feature is modelled in the
context of a hierarchical linear model (Lindley and Smith, 1972) estimated with Bayesian
techniques. As already shown in several studies, the panel-data hierarchical-model approach
uses the variability contained both in the cross-sectional and in the time-series dimensions
in a powerful way, allows the implementation of the relevant tests in a natural way, and is
easy to estimate, given the recent advances in Bayesian statistics and Markov Chain Monte
Carlo Methods (MCMC) techniques.
For our purposes, we assume that time series realisations fgitgTit=ti for n rms (i = 1; :::; n)
are available, possibly of di¤erent lengths. Each series starts at time ti and is generated by
an autoregressive model of order 1 (AR (1)). Without lack of generality, the minimum ti
equals 1. The last observation occurs at time Ti, for each rm. Assuming that there are no
missing observation between ti and Ti for each i, we let Ti = Ti   ti + 1 denote the number
of observations in the series for the ith rm. The initial conditions, gi0, are observed and
the subsequent estimation results are conditional on them. The following statistical model
is specied for each rm i:
git = i + igit 1 + it t  ti (3)
The random variables it are assumed to be normally and identically distributed, with mean
zero and variance 2i ; and are uncorrelated across units and over time, i.e.,
it j 2i  N
 
0; 2i

E
 
itjs

= 0; 8i 6= j; t 6= s (4)
Two additional features are worth mentioning. First, our model specication allows for an
intercept, i. Other studies (e.g. Bottazzi et. al., 2001) sometimes estimate a specication
equivalent to git = git 1 + uit, which, besides considering a common slope, avoids the
inclusion of the specic e¤ect i, as if the expected proportionate rates of growth were
zero. Second, another advantage of the hierarchical model adopted here is the possibility of
handling unbalanced panels in a natural way. Therefore, rms with di¤erent observations
can be included in the sample, which in turn allows us to both maximise the size of cross-
sectional observations and minimise the survival bias.
For the sake of simplicity, let i = (i; i)
0 and xit = (1; git 1)0. Equation (3) can then
be written in a more compact form as
git = x
0
iti + it; i = 1; 2; :::; n; t  ti (5)
8
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The hierarchical structure is introduced into Equation (5) with an exchangeable assumption
on the population structure
i  N (c;c) ; i = 1; 2; :::; n (6)
where c
 
= (c; c)
0 and c are the unknown common mean and variance-covariance ma-
trix, respectively. The chosen prior distribution assumes that intercept and slope of the
model do not di¤er too much across units, so the rm-specic parameter vector i is an
independent random draw from the underlying common distribution (6). The matrix c
controls the variability of the rm-specic regression parameter vector i. The standard
linear regression model with homogenous coe¢ cients (i = c) for each rm is obtained by
letting c be a null matrix.
A full implementation of the Bayesian approach is achieved here using the Gibbs sampler
(e.g. Gelfand et al, 1990 for illustration of general models, and Nandram and Petruccelli,
1997 for an application to autoregressive time series panel data), a recursive Monte Carlo
method which requires only knowledge of the full conditional posterior distribution of the
parameters. The analysis requires the specication of a prior for c; c and 2i : Assuming
independence, as is customary in the literature, we take
p
 
c;
 1
c ;

2i
	n
i=1

/ p (c)  p
 
 1c
  nY
i=1
p
 
2i

(7)
to have a Normal-Wishart-Inverse Gamma structure:
c  N (;C) (8)
 1c  W
 
so; S
 1
o

(9)
2i  IG

v
2
;

2

(10)
The notation  1c  W
 
so; S
 1
o

means that the matrix  1c is distributed as a Wishart
with scale S 1o and degrees of freedom so, while 2i  IG
 
v
2 ;

2

denotes an inverse gamma
distribution with shape =2 and scale =2. The hyperparameters ;C; so; So; v and  have
to be specied by the researcher. Concretely,  is the prior mean of the common mean
vector c; C controls the dispersion of our prior belief around c: the larger the C ma-
trix, the weaker the prior information on c; so, the degrees-of-freedom parameter of the
Wishart, controls the dispersion of  1c ; and S 1o the corresponding location: the bigger is
so relative to the size of the cross-section, n, and the smaller is So, the smaller is the prior
9
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mean of  1c making the prior on i more informative and shrinking i more towards the
common mean c; nally v and  control the shape and the scale of the prior distribution
for 2i : a less informative prior is obtained by letting v and  become smaller. In the follow-
ing section, results are reported under four di¤erent prior specications, by varying these
hyperparameters in a reasonable range.
Under this prior assumption, the conditional posterior distributions of the parameters 
i; 
2
i
	n
i=1
; c;c

are straightforward to derive.5 Bayesian point estimates and other
quantities of interest are obtained by taking appropriate averages over the useful Gibbs
sample draws, i.e. those draws for which convergence to the marginal posterior distributions
has been achieved. Gibrats law can be tested by comparing the model Mo : c = 1 against
M1 : c < 1. A nding that c is not statistically di¤erent from 1 would conrm the law as
holding over time and across rms. A third model specication, M2 : i = 1 (i = 1; :::; n)
can also be examined. A nding that i (i = 1; :::; n) is not statistically di¤erent from 1
would then be considered as the Gibrats law holding uniformly over individual rms. The
comparisons are based on the Bayes Factor (BF), that is the ratio of marginal data densities
under alternative models. These quantities are computed using the Gibbs output as in Chib
(1995).
Further implications of the law can then separately be examined.
First, we can compare the speed of adjustment (1  i) of each unit to its own steady
state, with the respective initial conditions, gi0, which is a question related to the mean
reversion argument and the decrease in the variance of the rm size over time. Using the
Gibbs draws for the individual i, we compute Pr fi < 1 j Y g, i.e. the posterior probability
that the autoregressive coe¢ cient for th ith rm is lower than the unit. The mean reversion
is checked by comparing this quantity with the initial conditions. A negative relationship
will provide evidence in favour of the mean reversion.
Also, we verify whether steady states are all equal across rms by comparing Ho : SSi =
SSj against H1 : SSi 6= SSj , 8i 6= j, where SSi is the steady state of rm i. Finally, if steady
states are not common, the model specication is easily used to verify whether the long-
run di¤erences across rms are transitory or permanent, i.e. whether there is persistence
in size di¤erences. The latter can be done by comparing the posterior distribution of the
steady states to the initial conditions. In particular, we compute the following probabilities:
p1 = (1=n1)
P
i Pi, and p2 = (1=n2)
P
iQi, where Pi = Pr fSSi < 0 j gi0 < 0; Y g is the
5The derivation of the posterior distributions can be found in the Working Paper version available at
http://www.uu.nl/content/05-02.pdf. There the reader can also nd a sensitivity analysis to investigate how
much our results change when we use other reasonable probability models.
10
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probability that the posterior steady state size is lower than the average, given that the
initial size is lower than the average, and Qi = Pr fSSi > 0 j gi0 > 0; Y g is the probability
that the posterior steady state size is greater than the average, given that the initial size is
greater than the average. n1 and n2 are the number of rms which started below and above
the average respectively. The higher p1 and p2, the more attractive are the initial conditions
and the more persistent are the initial di¤erences in size. The complementary probabilities,
1   p1 and 1   p2 will then provide the transition probabilities of going from low to high
and from high to low size respectively. A visual inspection of the size persistence argument
is also easily obtained by comparing both the average posterior steady state for each rm
(SSi =
 
L  L+ 1 1PLl=L SS(l)i ) and the unconditional probability q = (1=n)PiRi, where
Ri = Pr fSSi < 0 j Y g, with the initial conditions.
A measure of model t is also reported, in order to check that the model provides an
adequate t to the data. We use the Bayes p-value described in Gelman et al. (1995,
Ch. 6 and 12) and compare simulated values from the posterior predictive distribution of
replicated data to the observed data. Major failures of the model typically correspond to
extreme tail-area probabilities (less than 0.01 or more than 0.99).6
3 The Data
The pharmaceutical industry constitutes a particularly interesting testbed for Gibrats Law.
In fact, pharmaceuticals might be considered an ideal case where the process of rms growth
should behave in accordance with the Law of Proportionate E¤ects, as a consequence of the
peculiar role and nature of innovation in this industry. It is well known that pharmaceuticals
is a highly innovation-intensive industry. Moreover, the innovative process in this sector
has often been described and conceptualised as a pure lottery model, whereby previous
innovations (even in a particular submarket) do not inuence in any way current and future
innovation in the same or in other submarkets (Sutton, 2002).
Data come from the PHID (Pharmaceutical Industry Database) dataset, developed un-
der the EPRIS Program at C.E.R.M. (Center for the Economic Analysis of Competitive-
ness, Markets, and Regulation, Rome). The database provides longitudinal data for a
sample of 210 rms in the seven largest western markets (France, Germany, Italy, Spain,
UK, Canada, and USA) during the period 1987-1998. Values are in thousands of Pound
Sterlings at constant 1998 exchange rate. The values reported in the database regard only
6A more detailed description of the model t can be found in the Working Paper version available at
http://www.uu.nl/content/05-02.pdf.
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the pharmaceutical component of the companies total sales. The companies included in the
dataset result from selecting the largest 100 companies (in terms of sales) in each national
market. Since most of these companies are active in two or more national markets, cleaning
for the double-counting was necessary. We then obtain a total of 210 companies for the
seven largest western markets. The dataset has been constructed by aggregating the values
of the sales of these rms in the di¤erent national markets: therefore, sales for each rm
stand for the sum of their sales in each of the national markets in which they are active.
It is important to emphasise that the panel is unbalanced since processes of entry and exit
are explicitly considered.
A few comments of the data are in order here.
We use sales as proxy for rm size not only because of data availability, but also because
sales are usually considered the best available proxy of rm size in pharmaceuticals and in
some recent studies on rms growth (Hart and Oulton, 1996; Geroski et al., 1997, Higson
et al., 2002). Alternative measures are more di¢ cult to obtain on a longitudinal basis and
su¤er of a number of drawbacks. In particular, the use of employment - even if available
- would unduly increase the lumpiness of the growth process, especially as it concerns
divestiture, opening (or closure) of plants, R&D labs, etc., particularly as they occur at the
international level.7
The use of a broad geographical denition for the relevant market and the consideration
of the international rm - i.e. the sum of the sales in each national market - as the unit of
analysis is justied in our view by the global nature of competition in the pharmaceutical
industry. Many rms operate in di¤erent countries at the same time, when it concerns
R&D, production and marketing. More importantly, successful drugs are sold worldwide
and rms growth depends crucially on the ability to be present in di¤erent countries at the
same time. Hence, the world market - as approximated by the seven large countries for
which data were available - seems to us an appropriate level of aggregation for capturing
the locus of competition.
In terms of products, the market is dened here at the level of one single class at the 4
digit level of the Standard Industrial Classication, i.e. pharmaceutical products. In this
respect, the denition of the market is quite narrow. It could be argued that the pharma-
ceutical industry is actually constituted by a collection of several (independent) submarkets
or therapeutic categories, denable at extremely ne levels of disaggregation. Yet, rms
7Employment, assets, sales, market value, and value added are some of the most common measures of
company size. For a discussion on their advantages and their limits, see Hart and Oulton (1995).
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growth in this industry is fundamentally dependent on the process of diversication on a
variety of submarkets (Sutton, 2002; Bottazzi et al. 2001; Henderson et al., 1999). Thus,
focusing the analysis on a single (or few) submarket(s) would imply missing an essential
driver of rms growth.
In this paper we exclusively focus on the process of internal growth of rms. In order to
control for mergers and acquisitions during the period of observation, we construct virtual-
rms. These are rms actually existing at the end of the period, for which we construct
backward the series of their data in the case they merged or made an acquisition. Hence, if
two rms merged during the period, we consider them merged from the start, summing up
their sales from the beginning. This procedure might introduce a bias in the intertemporal
comparison of rms size distributions along time, but it has the advantage of emphasising
the changes in the distributions that derive strictly from intra-market competition (Bottazzi
et al. 2001, p.1168). Furthermore, by constructing "virtual rms" we avoid mixing the
phenomenon of pure (greeneld) entry with entry due to mergers. In fact, there is evidence
that greeneld entrants are smaller than average rms (Baldwin et al., 1995; Acs, 1996),
whereas entrants resulted from a merger are usually larger than average, like in the case
of the entry of Novartis in 1996 following the exit of Ciba-Geigy and Sandoz in 1995. Our
database conrms this nding: the greeneld entrants have smaller size than the average
and generally are the minimum values of the size distributions.
The methodology used to construct the dataset supports the use of the international
market as the relevant locus of competition.Though the smallest rms might seem under-
represented, however, our dataset is not constituted only or even mainly by large companies.
Descriptive statistics reported in the Working Paper version show that the sample includes
several small and medium sized companies.8 In fact, the rms size distribution is skewed
towards the smallest rms of the sample, since the skewness is always signicantly positive
and the median is always much smaller than the mean.
As expected, the variable we construct, git = ln
 
Sit= St

washes away the increasing
trend of the total sales over time, and removes the possible shocks common to all the rms
in the industry.9 In fact, the ratio of the standard deviation to the mean as well as to the
skewness and the kurtosis are nearly constant over time.Finally, notice that the minimum
number of observations in the series for each rm is Ti = 2 (for just one rm).
8The descriptive statistics can be found in the Appendix of the Working Paper version available at
http://www.uu.nl/content/05-02.pdf.
9See the variable Ln_dev87...98 in the descriptive statistics of the Working Paper version.
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4 Estimation results
In this section we present the empirical results. They are shown in Figures 1-9 and Tables
1-3.
The estimation results are reported under four prior specications. Table 1 describes
the chosen hyperparameters.
Table 1. Prior information
prior v  so So  C
A 10 1 k + 2 20  I  C
B Ti + 10 ^o k + 50 10  I ~ ~C
C 5 1 k + 2 20  I ~ 100  I
D 5 1 k + 50 10  I ~ ~C
The notation of the table is as follows:
1.  = 0:5
 
 + pool

, C = 0:5
 
C + Cpool

2.  = (1=N)
P
i ^i, with ^i = (X
0
iXi)
 1X 0iGi, pool = (X
0X) 1X0Y , where X =
diag (X1; :::; Xn) ;
3. C = (1=N)
P
i

^i   (1=N)
P
i ^i

^i   (1=N)
P
i ^i
0
, and Cpool = (X0X)
 1;
4. ~ = (0 0:96)0 and ~C = diag (10; 0:006);
5. ^o = (1=N)
P
i (Gi  X 0i)0 (Gi  X 0i).
The hyperparameters have been chosen following simple criteria and mixing sample
information, and previous empirical studies both on Gibrats law and on hierarchical models.
Prior A can be regarded as moderately non informative at all levels of the hierarchical
structure. Prior B is more informative than prior A in all respects. First, it has a bigger
so relative to the size of the cross-section, and a smaller So: both features imply a smaller
prior mean for  1c making the prior on i more informative and shrinking i more towards
the common mean c. Second, the mean and the variance of 2, i.e. the hyperprior mean of
c, have been taken from the previous empirical estimates of c in the literature as reported
in Goddard et al. (2002, pp.417, table 1). We t an empirical distribution on this estimates
and then compute its mean and variance. Figure 1 reports the histogram of these estimates.
Finally, the shape o and the scale o of the prior on the variance have been chosen to match
on average the sample variance.
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Prior C is less informative than priors A and B at all levels of the hierarchy. Prior D is
a mixture of priors B and C.
The Gibbs sampling is run in 4 cycles of 5000 iterations. Results are based on the last
5000 iterations, therefore discarding the rst 15000 draws. Convergence has been checked
following the method proposed by Brooks and Gelman (1998). It has been achieved already
after 10000 iterations, using di¤erent seeds of the random number generator and di¤erent
initial values of the unknown parameters.
Table 2 reports the mean and the 90% central part of the posterior distribution of c,
the model testing as explained above (Mo vs. M1, Mo vs. M2, M1 vs. M2, and Ho vs. H1),
the marginal likelihood, i.e., the posterior density of the data, (ln (m^ (y))) ; computed as in
Chib (1995) and the Bayes p-value (B-p) to check the model t of the data under the four
priors.
As a general comment, notice that Prior A ts the data well according to the particular
test quantity chosenand produces the highest posterior density as well. Therefore, most
of the results discussed below, especially those concerning mean reversion and persistence
of size di¤erences, are based on the output generated under Prior A. Results based on the
other priors are qualitatively identical and therefore omitted to avoid replications.
Table 2. Estimation and testing
prior c (5% 95%) ln (BF01) ln (BF02) ln (BF12) ln (BFss) ln (m^ (y)) B-p
A 0:92 (0:85 0:99)  6:19 420:94 427:13  823:66 2201:03 0:59
B 0:94 (0:88 1:01)  6:32 135:30 142:21  835:45 2163:02 0:03
C 0:93 (0:85 1:02)  4:72 453:53 458:25  818:20 1977:23 0:97
D 0:96 (0:91 1:01)  4:94 187:87 192:81  725:42 2110:99 0:99
Notes:BF01 comparesMo : c = 1 againstM1 : c < 1;BF02 comparesMo : c = 1 against
M1 : i = 1; i = 1; ::; n;BF12 comparesM1 : c < 1 againstM1 : i = 1; i = 1; ::; n;BFss
compares Ho : SSi = SSj against H1 : SSi 6= SSj ;8i 6= j: ln ( m^ ( y) )is the log mar-
ginal posterior density. B-p is the Bayes p-value (Gelman et al.,1995).
4.1 Does Gibrats law hold?
Table 1 shows that under all priors the numerical estimate of c is di¤erent from 1. This
can also be seen in the plots of the posterior densities of c (Figure 2). It is worth noting
that in almost all cases the posterior distribution contains 1. However, the values of the
Bayes factor BF01, which compare Mo : c = 1 against M1 : c < 1, are always lower than
1. To interpret these numbers, one can compute the highest prior probability to assign to
15
Page 15 of 32 
Ac
ce
pte
d M
an
us
cri
pt
model M1 in order to obtain posterior odds in favour of Mo. If  is the prior probability of
model M1, the Posterior Odds ratio is dened as the product of the prior odds ratio and
the Bayes Factor:
PO =
1  

BF:
Therefore, the highest prior probability to assign to model M1 in order to obtain posterior
odds (just) in favour of Mo is  = 1= (1 + exp (1  ln (BF01))). Hence, for instance, under
prior C one should assign at most  = 0:00327 toM1 for the data to change the conclusion
and make the posterior inference favourable to Mo. Such a small probability would imply
an implausible prior odds ratio of 304.8 in favour ofMo. We consider these numbers as clear
evidence against model Mo as compared to M1. The former is however strongly favoured
when compared to model M2, meaning that the posterior density of the sample data is
much higher when we impose an average random walk across rm than when we impose
the same assumption to all individual rms. Finally, M2 is a fortiori not favoured when
compared to model M1.
Overall, these ndings do not conrm that Gibrats law holds on average, over time and
across rms. The histogram of i, the posterior mean of i (i = 1; :::; n) averaged across
rms (notation above), provides a rst visual inspection of the nding that several rms
are far from following Gibrats Law (Figure 3). An interesting issue is to check which
rms do follow the law. A further straightforward analysis shows clearly that large rms
have a posterior distribution of i centred on unity. Figure 4 (chart a) plots the posterior
distribution of i for top 10% rms, i.e. rms whose initial size is in the top decile of the
initial distribution of sizes. The picture conrms the intuition that large rms do follow
Gibrats law, in line with previous nding of the literature (e.g. Hall 1987, Lotti et al.2003).
The marginal likelihood (ln m^ (y)) of the model under prior A and the restriction that i = 1
for the top 10% rms is equal to 2146.58. The same gure is only 1849.38 when we restrict
all the other rms to have i = 1. The positive Bayes factor resulting from the di¤erence
between the former and the latter provides odds in favour of the hypothesis that the size
of large rms follows a random walk, even though the model without any restrictions (and
under the same prior) has a higher posterior density (2201.03), as shown in Table 1. This
implies that the sample data prefer a model where no random walk restriction is imposed
on any rms.
On the contrary, if we look at the rms whose initial size belongs to the rst decile of
the distribution (bottom 10%, Figure 4b) we see that the posterior distributions are not
centred on the unity, conrming that initially small rms do not follow Gibrats law and
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have a higher speed of convergence to the steady state than initially large rms, which
may have already reached their own steady states. These claims are also summarised in
Figure 5 (charts "a" and "b"), which show the scatter plots of the average posterior speed
of convergence versus the initial sizes. In chart "b" the top 10% and the bottom 10% have
been excluded from the sample. The gures conrm that for very small rms the average
convergence speed is far away from zero, while for very large rms is around zero (chart
"a"). The evidence shows no clear pattern when the remaining rms are considered (chart
"b").
In sum, these results seem to conrm previous ndings that Gibrats Law holds only
for very large rms but not for the others. The Law appears to hold only for 15% of the
rms in our sample. Moreover, the failure of Gibrats Law and the observation of higher
convergence rates for small rms do not necessarily imply mean reversion.
4.2 Do data show mean reversion?
From the same plots an initial assessment of the mean reversion argument can be drawn.
Do smaller rms have a higher speed of convergence than larger rms? As argued above,
this seems to be true only when the rst and the last decile of the initial size distribution
are compared. If we take the "extreme-size" rms out of the sample,there is no evidence of
a negative relation between speed of convergence and initial size.
The argument against strong evidence of mean reversion stands also when considering
the entire posterior distribution of i and not just its posterior mean. Figure 6 shows the
relation between the initial condition and the posterior probability of i being lower than
unity, i.e., Pr (i < 1 j Y ). In chart "a" all rms are considered; in chart "b" we again
exclude the top and the bottom 10%. As from the previous scatter plots, it can be argued
that it is indeed true that for very small rms Pr (i < 1 j Y ) is quite high while for very
large rms the same probability is low. However, when considering only the central 80
percent rms of the initial size distribution, this relation is very weak. We therefore cannot
express a posterior condence in favour of a mean-reversion claim. Finally, to the extent that
mean reversion actually operates,the process is still very slow indeed, given the observed
values of the speed of convergence (Figures 5a and 5b)
4.3 Are the steady states equal?
But do rms sizes converge to the same steady state, as it would be implied by a strict
interpretation of the mean reversion argument? Table 2 (column 6: ln(BFss)) shows that
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under all priors the Bayes factor overwhelmingly favours the model where steady states
are not restricted to be equal. The evidence is reinforced by Figure 7, where the posterior
distributions of the steady states of 10% randomly chosen rms are plotted. Both the Bayes
factor and the chart support the evidence that the rms in the sample have very di¤erent
steady states, conrming once more not only that Gibrats Law does not hold on average,
but also that rms do not converge to the same size. These results suggest that rm-specic
characteristics are very important in determining rms growth.
4.4 Do initial di¤erences in size persist?
Gibrats Law would imply that initial size di¤erences would not tend to persist. The mean
reversion argument would suggest that persistence of size di¤erentials should be quite low,
as small rms grow faster than large ones, even if the steady state sizes are di¤erent.
Here, we check the persistence of size di¤erences. Figure 8 plots the posterior mean of the
steady states versus the initial conditions. The positive relation favours the conclusion that
di¤erences across rms are persistent,depending strongly on their initial size.
In order to consider both the uncertainty on the steady state resulting from the model
and the posterior mean, we further investigate the relation between the entire posterior dis-
tributions of steady states and the initial condition. First, dividing the initial sample into
rms below and above the average, we plot the scatter points of the unconditional probabil-
ity q = (1=n)
P
iRi, where Ri = Pr fSSi < 0 j Y g ; against the initial conditions. Figure 9
reinforces our rst preliminary conclusion on the persistence, namely that most of the small-
est rms have a high posterior probability of remaining below the average, while for almost
all largest rms the same probability is negligible. Second, we compute the posterior prob-
abilities p1 = (1=n1)
P
i Pi, and p2 = (1=n2)
P
iQi, where Pi = Pr fSSi < 0 j gi0 < 0; Y g is
the probability that the posterior size steady state is lower than the average, given that the
initial size is lower than the average, and Qi = Pr fSSi > 0 j gi0 > 0; Y g is the probability
that the posterior steady state size is greater than the average, given that the initial size is
greater than the average. Results give p1 = 0:77 and p2 = 0:80, meaning that the probabil-
ity of remaining in the same initial position is almost 80 per cent for both states (below and
above the average) or, that there is only a 20 percent probability for a rm which starts
below (above) the average to reach a steady state above (below) the average.
The same analysis can be rened by considering more quantiles of the initial size dis-
tribution and not just the mean. Table 3 reports the average probabilities that a rm in a
certain quartile of the initial conditions distribution will end up in a quartile of the steady
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states distribution. For instance, cell (1,1) reports the average probability of a rm initially
in the rst quartile to have its steady state again in the rst quartile; cell (2,1) reports the
average probability of a rm initially in the rst quartile to have its steady state in the sec-
ond quartile; and so on. Therefore, the average probability of remaining in the same initial
position is reported on the main diagonal, whereas the o¤ diagonal elements represent the
transition probabilities of moving from one state to another.
Probabilities in Table 3 reinforce previous results: initial conditions in rms size matter
for the rms position in the steady state distribution. The probabilities of remaining in the
same quartile of the distribution are always larger than those of moving into other quartiles,
especially in the upper part of the distribution. It is worth noting that the state showing
the highest persistence is the last quartile: rms initially larger than the average are very
likely to end up also in steady states much larger than the average.
In sum, these results indicate not only that Gibrats Law is violated in our sample, but
also that mean reversion is very weak: smaller rms tend to remain small and larger rms
tend to remain large. Moreover, the speed of convergence to such steady state is very slow.
Table 3. Persistence of di¤erences
Initial  25% 25%  50% 50%  75% > 75%
Steady state
 10% 0:5219 0:3184 0:1251 0:0372
25%  50% 0:2652 0:4582 0:2577 0:0240
50%  75% 0:1296 0:1506 0:5263 0:1840
> 90% 0:0833 0:0728 0:0909 0:7548
5 Summary and concluding remarks
The results of this paper can be summarised as follows:
(i) The main assertion of Gibrats law that growth rates are erratic is not true on average,
across rms and over time. The estimated average speed of adjustment is far from being
zero on average when both cross-sectional and time-series information is used. However,
the nding that the growth of initially very large rms follows a random walk is conrmed
here.
(ii) Data show only a very weak evidence of mean reversion. Even if on average c < 1,
this does not necessarily mean that initially larger rms grow slower than smaller rms.
Our analysis shows that the relative speed of convergence of smaller rms is not necessarily
higher than the one of larger rms, except in the extreme tails of the distribution.
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(iii) More important, rm sizes do not converge to a common limiting distribution but
to rm-specic steady state size: estimated steady states di¤er across units . This fact does
not imply per se that rm size drifts unpredictably over time, as argued by some authors
(see Geroski, 1999, and Geroski at al. 2003). It is true that a unit root in the process of
rm size implies divergence, but the reverse causality does not necessarily hold, as shown
in this paper.
(iv) Initial conditions are important determinants of the estimated distribution of steady
states. Initial size di¤erences do not seem to disappear over time and when they do, the
rate is very slow. Thus, a rm with an initial size below the average will narrow the gap
somewhat with respect to larger rms, but it does not seem to increase its relative size in
the cross sectional distribution. In other words, di¤erences in rms size persist.
(vi) The model used does not show failings in tting to data. Moreover, results are
unchanged using alternative models.
In sum, our results contradict two basic implications of both Gibrats Law and the
"generalised" mean reversion argument: almost no correlation is observed between initial
size and speed of adjustment, while a strong correlation is found between initial size and
the steady state. Thus, there seem to be systematic di¤erences in growth rates among
rms that are not size-specic and may depend on other rm-specic features that are not
observable in our data. Given that these results are su¢ ciently robust to di¤erent prior
specications, they create space for investigating further the determinants of rms growth.
Most likely, size is not the only variable growth should be conditioned on. Other sources
of heterogeneity (age being a primary - but certainly not the only - candidate) may more
plausibly be responsible for di¤erential growth rates of rms over time. In particular it
would be interesting to explore some common features across clearly divergent/convergent
rms, as well as the role of other variables in explaining the cross sectional dispersion in
estimated steady states. Finally, the mechanisms through which market selection operates
in promoting the growth and the decline of rms should also be explicitly modelled and
tested.
At a more general level, the results of this paper strengthens once more the argument
that extreme attention has to be given to treating heterogeneity appropriately in economet-
ric models.
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Figure 1. Histogram of previous estimates of ρ c . Source: Goddard et al. (2002)
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Figure 2. Posterior distribution of ρ c  under the four priors
Figure 3. Histogram of posterior mean of ρ i
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Figure 4a. Posterior distribution of ρ i . Top 10% firms
Figure 4b. Posterior distribution of ρ i . Bottom  10% firms
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Figure 5a. Speed of convergence: all firms
Figure 5b. Speed of convergence: excluding 10% tails
-0.1
0
0.1
0.2
0.3
0.4
0.5
-8 -6 -4 -2 0 2 4
Initial condition
C
on
ve
rg
en
ce
 ra
te
-0.1
0
0.1
0.2
0.3
0.4
0.5
-4.3 -3.3 -2.3 -1.3 -0.3 0.7
Initial condition
C
on
ve
rg
en
ce
 ra
te
Page 29 of 32 
Ac
ce
pte
d M
an
us
cri
pt
Figure 6a.  Mean reversion. All firms.
Figure 6b.  Mean reversion without 10% tails
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Figure 7.  Posterior distributions of steady state. Randomly selected firms.
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Figure 8. Average steady states and initial conditions
Figure 9. Persistence of differences
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